These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15040562)

  • 1. Research for control: the onchocerciasis experience.
    Remme JH
    Trop Med Int Health; 2004 Feb; 9(2):243-54. PubMed ID: 15040562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
    Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
    Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2013.
    Wkly Epidemiol Rec; 2013 Dec; 88(50):533-44. PubMed ID: 24367839
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
    Duerr HP; Eichner M
    Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
    Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
    Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
    Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
    Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting of the International Task Force for Disease Eradication, April 2011.
    Wkly Epidemiol Rec; 2011 Aug; 86(32):341-51. PubMed ID: 21837843
    [No Abstract]   [Full Text] [Related]  

  • 15. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
    Wkly Epidemiol Rec; 2012 Dec; 87(49/50):494-502. PubMed ID: 23311005
    [No Abstract]   [Full Text] [Related]  

  • 16. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
    Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
    Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The African Programme for Onchocerciasis Control (APOC).
    Amazigo U
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African Programme for Onchocerciasis Control: meeting of National Task Forces, September 2011.
    Wkly Epidemiol Rec; 2011 Nov; 86(48):541-9. PubMed ID: 22128386
    [No Abstract]   [Full Text] [Related]  

  • 20. Research for new drugs for elimination of onchocerciasis in Africa.
    Kuesel AC
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.